SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-18-002938
Filing Date
2018-07-17
Accepted
2018-07-16 17:36:58
Documents
65
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 495795
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 74609
3 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7334
4 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7391
5 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2397
6 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2421
13 GRAPHIC exhibit10-1x1x1.jpg GRAPHIC 8679
14 GRAPHIC exhibit10-1x15x1.jpg GRAPHIC 20547
  Complete submission text file 0001062993-18-002938.txt   4926080

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE orgs-20180531.xml EX-101.INS 749419
8 XBRL SCHEMA FILE orgs-20180531.xsd EX-101.SCH 105625
9 XBRL CALCULATION FILE orgs-20180531_cal.xml EX-101.CAL 59563
10 XBRL DEFINITION FILE orgs-20180531_def.xml EX-101.DEF 438928
11 XBRL LABEL FILE orgs-20180531_lab.xml EX-101.LAB 718631
12 XBRL PRESENTATION FILE orgs-20180531_pre.xml EX-101.PRE 487461
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 18955150
SIC: 2834 Pharmaceutical Preparations